News & Events
-
4th Annual IPF Summit 2020
When:
Anima Biotech’s vice president of research and development, Iris Alroy, Ph.D., has been invited to give an overview of the company’s lung-specific modulators of collagen translation and recent in vivo data at the 4th Annual IPF Summit. Dr. Alroy’s presentation titled “Found in Translation: Targeting Collagen I Protein Synthesis as a Novel Therapeutic Approach for IPF,” will take place on Tuesday, Aug. 25 at 2 p.m. ET.
This year’s IPF Summit will be entirely digital as the only and most comprehensive summit committed to addressing the translational and clinical challenges limiting the idiopathic pulmonary fibrosis industry from transforming patient’s lives with more effective and meaningful drug development. The summit attracts cross-industry experts alongside pioneering academics from IPF drug sponsors to those strategically assessing anti-fibrotic drug development for archetypal fibrotic diseases. The conference highlights the latest interrogation of pathophysiology, genetics, and drug mechanisms to constructively outlining the lumping versus splitting debate, and a world with COVID-19 to advance the IPF drug development frontier.
-
BIO Digital Week
When:
Anima Biotech has been invited to present an overview of its Translation Control Therapeutics Platform for the discovery of small molecule drugs that control mRNA translation and provide an update on its drug discovery pipeline during the 2020 BIO Digital Week.
The conference, a virtual format for the annual BIO International Convention, is bringing together more than 6,500 attendees from 64 countries around the world for an exciting week of BIO One-on-One partnering, critical education and thought leaders discussing the most pressing industry topics.
-
13th Annual European Life Sciences CEO Forum
When:
Where: Zurich, SwitzerlandAnima Biotech has been invited to present an overview of its Translation Control Therapeutics Platform for the discovery of small molecule drugs that control mRNA translation during the 13th Annual European Life Sciences CEO Forum.
The conference serves as a global biopharma industry forum that addresses the main challenges for 2020 investment, partnering and alliance management. Key players contribute their insights via panels, which cover the macro picture and innovation in different therapeutic sectors. The forum also features keynote speeches by KOLs and approximately 60 corporate presentations from established public and private emerging biotech companies.
-
2020 BIO CEO & Investor Conference
When:
Where: New York, USAAnima Biotech has been invited to present an overview of its Translation Control Therapeutics Platform for the discovery of small molecule drugs that control mRNA translation during the 2020 BIO CEO & Investor Conference.
Now in its 22nd year, the BIO CEO & Investor Conference is one of the largest independent investor conferences focused on established and emerging publicly traded and select private companies. The conference prides itself on showcasing the best of biotech with two days of productive partnering meetings with institutional and early-stage investors, industry analysts and senior biotechnology executives.
-
6th Annual LSX World Congress
When:
Where: London, UKAnima Biotech has been invited to present an overview of its Translation Control Therapeutics Platform for the discovery of small molecule drugs that control mRNA translation during the 6thAnnual LSX World Congress. Yochi Slonim, Co-founder and Chief Executive Officer of Anima Biotech, will also participate with other experts as part of the “Platforms and Partnerships” panel.
For five years, the LSX World Congress has been bringing together the executives that matter to the future of healthcare and life science business strategy, investment, partnering, deal-making, and commercialization. The LSX World Congress gathers the founders and CEOs of innovative start-ups through to publicly listed life science giants and everyone in between. It represents the breadth and depth of the cutting-edge research and technology driving the advances in the industry right now and in the near future.
-
Biotech Showcase 2020
When:
Where: San Francisco, USAAnima Biotech has been invited to present an overview of its Translation Control Therapeutics Platform for the discovery of small molecule drugs that control mRNA translation during the Biotech ShowcaseTM 2020.
Biotech Showcase™ is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place. Investors and biopharmaceutical executives from around the world gather in San Francisco during this important week which sets the tone for the coming year. Now in its twelfth year, this rapidly growing conference features multiple tracks of presenting companies, plenary sessions, workshops, networking, and an opportunity to schedule one-to-one meetings.
-
2nd RNA- Targeted Drug Discovery Summit 2019
When:
Where: Boston, USAAnima Biotech has been invited to present an overview of its Translation Control Therapeutics Platform for the discovery of small molecule drugs that control mRNA translation during the 2nd RNA- Targeted Drug Discovery Summit 2019. Yochi Slonim, Co-founder and Chief Executive Officer of Anima Biotech, will also participate with other experts as part of the “Targeting RNA with Small Molecules to Capture the Therapeutic Opportunities” panel.
With numerous approaches emerging that demonstrate genuinely viable efficacy in targeting RNA, the 2nd RNA- Targeted Drug Discovery Summit is the only industry and translational focused conference dedicated to advancing pioneering RNA targeted small molecule therapeutics. For the 2nd year, at this event KOLs and RNA pioneers join to gain a comprehensive understanding on how to translate the first generation of RNA targeted small molecules into the clinic, delve into the exciting field of epitranscriptomics and stimulate discussion on how to successfully target RNA via RNA- modifying enzymes and interfering with RNA-protein interactions.
-
Targeting RNA
When:
Where: Frankfurt, GermanyAnima Biotech has been invited to present a talk on novel targets for small molecules between transcription and translation for lung fibrosis where they will discuss the discovery of lung-specific modulators of collagen translation and give insights into its Translation Control Therapeutics Platform for the discovery of small molecule drugs that control mRNA translation during the Targeting RNA Europe Congress 2019. Dr. Iris Alroy, Vice President of R&D of Anima Biotech, will also participate in a roundtable discussion on “Discussing RNA Functionality Issues such as Selectivity, Binding, Stability and Specificity” and in the “Treating the Unmet Need: Unleashing the RNA Space With Small Molecules” panel.
The Targeting RNA Congress explores the ‘undruggable’ RNA space and showcases the latest advancements in modulation of RNA directly with small molecules and through epigenetics. The meeting brings together academic and industry leaders who are building platforms to identify and validate targets in order to assess disease relevance approaches in the RNA world.
-
BIO-Europe
When:
Where: Hamburg, GermanyAnima Biotech has been invited to present an overview of its Translation Control Therapeutics Platform for the discovery of small molecule drugs that control mRNA translation during the 25th Annual BIO-Europe International Partnering Conference.
BIO-Europe is Europe’s largest life science partnering conference offering countless opportunities to engage with global life science partners. This event features workshops and panels discussing the latest industry trends in biotech and pharma as well as company presentations and one-on-one partnering meetings.
-
BIO Investor Forum
When:
Where: San Francisco, USAAnima Biotech has been invited to present an overview of its Translation Control Therapeutics Platform for the discovery of small molecule drugs that control mRNA translation during the 2019 BIO Investor Forum.
The BIO Investor Forum is an international biotech investor conference focused on investment trends and opportunities in life sciences, with unbiased emphasis on venture-stage growth and emerging public companies as well as those poised to join the growth “watch list” in 2020. The event features plenary sessions, business roundtables and therapeutic workshops, company presentations, and BIO One-on-One Partnering™ meetings.